| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2023―Oct―20 |
Hematopoietic memory of severe COVID-19 infection |
Anaisa V. Ferreira, Mihai G. Netea |
| 2 |
[GO] |
2023―Sep―27 |
A broadly neutralizing antibody inhibits SARS-CoV-2 variants through a novel mechanism of disrupting spike trimer integrity |
Yunping Ma, Qiyu Mao, Yingdan Wang, Zhaoyong Zhang, Jiali Chen, Aihua Hao, Palizhati Rehati, Yanqun Wang, Yumei Wen, Lu Lu, Zhenguo Chen, Jincun Zhao, Fan Wu, Lei Sun, Jinghe Huang |
| 3 |
[GO] |
2023―May―23 |
Bacterial coinfections contribute to severe COVID-19 in winter |
Hui Fan, Li Zhou, Jingjun Lv, Shimin Yang, Guozhong Chen, Xinjin Liu, Chunyan Han, Xue Tan, Shengnan Qian, Zegang Wu, Shan Yu, Ming Guo, Chengliang Zhu, Yu Chen, Ke Lan |
| 4 |
[GO] |
2023―Feb―15 |
ZBP1 inflames the SARS-CoV-2-infected lung |
Chaoran Yin, Siddharth Balachandran |
| 5 |
[GO] |
2023―Jan―25 |
Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection |
Bo Gao, Liheng He, Yujie Bao, Yingying Chen, Guanzhu Lu, Yu Zhang, Yingjie Xu, Bing Su, Jie Xu, Ying Wang, Leng-Siew Yeap |
| 6 |
[GO] |
2023―Jan―17 |
SARS-CoV-2 Z-RNA activates the ZBP1-RIPK3 pathway to promote virus-induced inflammatory responses |
Shufen Li, Yulan Zhang, Zhenqiong Guan, Meidi Ye, Huiling Li, Miaomiao You, Zhenxing Zhou, Chongtao Zhang, Fan Zhang, Ben Lu, Peng Zhou, Ke Peng |
| 7 |
[GO] |
2023―Jan―02 |
Towards developing a variant-proof SARS-CoV-2 vaccine |
Hua Peng, Yang-Xin Fu |
| 8 |
[GO] |
2022―Nov―10 |
A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein |
Wei Pang, Ying Lu, Yan-Bo Zhao, Fan Shen, Chang-Fa Fan, Qian Wang, Wen-Qiang He, Xiao-Yan He, Ze-Kai Li, Tao-Tao Chen, Cui-Xian Yang, You-Zhi Li, Si-Xuan Xiao, Zu-Jiang Zhao, Xu-Sheng Huang, Rong-Hua Luo, Liu-Meng Yang, Mi Zhang, Xing-Qi Dong, Ming-Hua Li, Xiao-Li Feng, Qing-Cui Zhou, Wang Qu, Shibo Jiang, Songying Ouyang, Yong-Tang Zheng |
| 9 |
[GO] |
2022―Sep―27 |
Deep learning-based rapid generation of broadly reactive antibodies against SARS-CoV-2 and its Omicron variant |
Hantao Lou, Jianqing Zheng, Xiaohang Fang, Zhu Liang, Meihan Zhang, Yu Chen, Chunmei Wang, Xuetao Cao |
| 10 |
[GO] |
2022―Sep―21 |
Proviral role of caspase-6 in coronavirus infections |
Lok-Yin Roy Wong, Stanley Perlman |
| 11 |
[GO] |
2022―Sep―14 |
mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2 |
Yuxuan Han, Yaling An, Qian Chen, Kun Xu, Xueyuan Liu, Senyu Xu, Huixin Duan, Annette B. Vogel, Uğur Şahin, Qihui Wang, Lianpan Dai, George F. Gao |
| 12 |
[GO] |
2022―Sep―01 |
Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment |
Markus Hoffmann, Yeonhwa Jin, Stefan Pöhlmann |
| 13 |
[GO] |
2022―Jul―29 |
Hetero-bivalent nanobodies provide broad-spectrum protection against SARS-CoV-2 variants of concern including Omicron |
Huan Ma, Xinghai Zhang, Peiyi Zheng, Peter H. Dube, Weihong Zeng, Shaohong Chen, Qingyu Cheng, Yunru Yang, Yan Wu, Junhui Zhou, Xiaowen Hu, Yan Xiang, Huajun Zhang, Sandra Chiu, Tengchuan Jin |
| 14 |
[GO] |
2022―Jun―29 |
A broadly neutralizing antibody against SARS-CoV-2 Omicron variant infection exhibiting a novel trimer dimer conformation in spike protein binding |
Yingdan Wang, Wuqiang Zhan, Jiangyan Liu, Yanqun Wang, Xiang Zhang, Meng Zhang, Lin Han, Yunping Ma, Lu Lu, Yumei Wen, Zhenguo Chen, Jincun Zhao, Fan Wu, Lei Sun, Jinghe Huang |
| 15 |
[GO] |
2022―Jun―14 |
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults |
Xiaoqiang Liu, Yuhua Li, Zhongfang Wang, Shouchun Cao, Weijin Huang, Lin Yuan, Yi-Jiao Huang, Yan Zheng, Jingjing Chen, Bo Ying, Zuoyun Xiang, Jin Shi, Jincun Zhao, Zhen Huang, Cheng-Feng Qin |
| 16 |
[GO] |
2022―Jun―07 |
Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages |
Lei Wang, Wangjun Fu, Linlin Bao, Zijing Jia, Yuxia Zhang, Yunjiao Zhou, Wei Wu, Jianbo Wu, Qianqian Zhang, Yidan Gao, Kang Wang, Qiao Wang, Chuan Qin, Xiangxi Wang |
| 17 |
[GO] |
2022―Apr―13 |
Enhanced trimeric ACE2 exhibits potent prophylactic and therapeutic efficacy against the SARS-CoV-2 Delta and Omicron variants in vivo |
Mengjiao Li, Zi-Wei Ye, Kaiming Tang, Liang Guo, Wenwen Bi, Yuyuan Zhang, Yan-dong Tang, Guoguang Rong, Mohamad Sawan, Xin Yin, Ren Sun, Shuofeng Yuan, Bobo Dang |
| 18 |
[GO] |
2022―Apr―13 |
Structural insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction |
Jun Lan, Xinheng He, Yifei Ren, Ziyi Wang, Huan Zhou, Shilong Fan, Chenyou Zhu, Dongsheng Liu, Bin Shao, Tie-Yan Liu, Qisheng Wang, Linqi Zhang, Jiwan Ge, Tong Wang, Xinquan Wang |
| 19 |
[GO] |
2022―Apr―01 |
Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2 |
Yunqing Gu, Jun Cao, Xinyu Zhang, Hai Gao, Yuyan Wang, Jia Wang, Juan He, Xiaoyi Jiang, Jinlan Zhang, Guanghui Shen, Jie Yang, Xichen Zheng, Gaowei Hu, Yuanfei Zhu, Shujuan Du, Yunkai Zhu, Rong Zhang, Jianqing Xu, Fei Lan, Di Qu, Guoliang Xu, Yun Zhao, Dong Gao, Youhua Xie, Min Luo, Zhigang Lu |
| 20 |
[GO] |
2022―Mar―21 |
Lipid nanoparticle-mRNA: another step in the fight against COVID-19 |
Abhishek Kumar Verma, Stanley Perlman |
| 21 |
[GO] |
2022―Mar―15 |
The P132H mutation in the main protease of Omicron SARS-CoV-2 decreases thermal stability without compromising catalysis or small-molecule drug inhibition |
Michael Dominic Sacco, Yanmei Hu, Maura Verenice Gongora, Flora Meilleur, Michael Trent Kemp, Xiujun Zhang, Jun Wang, Yu Chen |
| 22 |
[GO] |
2022―Mar―08 |
Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209 |
Bin Ju, Qingbing Zheng, Huimin Guo, Qing Fan, Tingting Li, Shuo Song, Hui Sun, Senlin Shen, Xinrong Zhou, Wenhui Xue, Lingyan Cui, Bing Zhou, Shaowei Li, Ningshao Xia, Zheng Zhang |
| 23 |
[GO] |
2022―Mar―08 |
Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine |
Hua Peng, Yang-Xin Fu |
| 24 |
[GO] |
2022―Feb―24 |
Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters |
Yong-Qiang Deng, Na-Na Zhang, Yi-Fei Zhang, Xia Zhong, Sue Xu, Hong-Ying Qiu, Tie-Cheng Wang, Hui Zhao, Chao Zhou, Shu-Long Zu, Qi Chen, Tian-Shu Cao, Qing Ye, Hang Chi, Xiang-Hui Duan, Dan-Dan Lin, Xiao-Jing Zhang, Liang-Zhi Xie, Yu-Wei Gao, Bo Ying, Cheng-Feng Qin |
| 25 |
[GO] |
2022―Feb―24 |
A pan-sarbecovirus vaccine induces highly potent and durable neutralizing antibody responses in non-human primates against SARS-CoV-2 Omicron variant |
Zezhong Liu, Jasper Fuk-Woo Chan, Jie Zhou, Meiyu Wang, Qian Wang, Guangxu Zhang, Wei Xu, Kenn Ka-Heng Chik, Yilong Zhang, Youchun Wang, Kwok-Yung Yuen, Lu Lu, Shibo Jiang |
| 26 |
[GO] |
2022―Feb―14 |
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant |
Na-Na Zhang, Rong-Rong Zhang, Yi-Fei Zhang, Kai Ji, Xiao-Chuan Xiong, Qian-Shan Qin, Peng Gao, Xi-Shan Lu, Hang-Yu Zhou, Hai-Feng Song, Bo Ying, Cheng-Feng Qin |
| 27 |
[GO] |
2022―Jan―27 |
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant |
Shuai Xia, Jasper Fuk-Woo Chan, Lijue Wang, Fanke Jiao, Kenn Ka-Heng Chik, Hin Chu, Qiaoshuai Lan, Wei Xu, Qian Wang, Chao Wang, Kwok-Yung Yuen, Lu Lu, Shibo Jiang |
| 28 |
[GO] |
2022―Jan―21 |
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates |
Denisa Bojkova, Marek Widera, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl |
| 29 |
[GO] |
2022―Jan―20 |
SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination |
Pengfei Li, Yining Wang, Marla Lavrijsen, Mart M. Lamers, Annemarie C. de Vries, Robbert J. Rottier, Marco J. Bruno, Maikel P. Peppelenbosch, Bart L. Haagmans, Qiuwei Pan |
| 30 |
[GO] |
2022―Jan―12 |
Loss of Spike N370 glycosylation as an important evolutionary event for the enhanced infectivity of SARS-CoV-2 |
Shuyuan Zhang, Qingtai Liang, Xinheng He, Chongchong Zhao, Wenlin Ren, Ziqing Yang, Ziyi Wang, Qiang Ding, Haiteng Deng, Tong Wang, Linqi Zhang, Xinquan Wang |
| 31 |
[GO] |
2021―Dec―13 |
Novel SARS-CoV-2 receptors: ASGR1 and KREMEN1 |
Markus Hoffmann, Stefan Pöhlmann |
| 32 |
[GO] |
2021―Nov―26 |
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2 |
Yunqing Gu, Jun Cao, Xinyu Zhang, Hai Gao, Yuyan Wang, Jia Wang, Juan He, Xiaoyi Jiang, Jinlan Zhang, Guanghui Shen, Jie Yang, Xichen Zheng, Gaowei Hu, Yuanfei Zhu, Shujuan Du, Yunkai Zhu, Rong Zhang, Jianqing Xu, Fei Lan, Di Qu, Guoliang Xu, Yun Zhao, Dong Gao, Youhua Xie, Min Luo, Zhigang Lu |
| 33 |
[GO] |
2021―Nov―23 |
Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern |
Jingwen Ai, Haocheng Zhang, Qiran Zhang, Yi Zhang, Ke Lin, Zhangfan Fu, Jieyu Song, Yuanhan Zhao, Mingxiang Fan, Hongyu Wang, Chao Qiu, Yang Zhou, Wenhong Zhang |
| 34 |
[GO] |
2021―Nov―04 |
Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2 |
Shaojun Zhang, Wenze Huang, Lili Ren, Xiaohui Ju, Mingli Gong, Jian Rao, Lei Sun, Pan Li, Qiang Ding, Jianwei Wang, Qiangfeng Cliff Zhang |
| 35 |
[GO] |
2021―Oct―26 |
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms |
Rongjia Zhu, Tingdong Yan, Yingmei Feng, Yan Liu, Hongcui Cao, Gongxin Peng, Yanlei Yang, Zhen Xu, Jingqi Liu, Wei Hou, Xiaoyue Wang, Zhe Li, Luchan Deng, Shihua Wang, Jing Li, Qin Han, Hongling Li, Guangliang Shan, Yinghao Cao, Xingyan An, Jianshe Yan, Zhonghui Zhang, Huafei Li, Xuebin Qu, Jiaqi Zhu, Shumin Zhou, Jiao Wang, Fengchun Zhang, Jinming Gao, Ronghua Jin, Dayong Xu, Yan-Qing Ma, Tao Huang, Shuang Peng, Zhi Zheng, Ilia Stambler, Eric Gilson, Lee Wei Lim, Alexey Moskalev, Antonio Cano, Sasanka Chakrabarti, Brun Ulfhake, Huanxing Su, Haoying Xu, Sihuan Xu, Feng Wei, Holly M. Brown-Borg, Kyung-Jin Min, Georgina Ellison-Hughes, Calogero Caruso, Kunlin Jin, Robert Chunhua Zhao |
| 36 |
[GO] |
2021―Oct―18 |
SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation |
Gang Xu, Ying Li, Shengyuan Zhang, Haoran Peng, Yunyun Wang, Dekang Li, Taijie Jin, Zhuohao He, Yilun Tong, Chunting Qi, Guowei Wu, Kangyun Dong, Jizhou Gou, Yang Liu, Tongyang Xiao, Jing Qu, Liang Li, Liang Liu, Ping Zhao, Zheng Zhang, Junying Yuan |
| 37 |
[GO] |
2021―Oct―12 |
Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2pos subjects |
Shanhe Yu, Caixia Di, Shijun Chen, Mingquan Guo, Jiayang Yan, Zhaoqin Zhu, Li Liu, Ruixue Feng, Yinyin Xie, Ruihong Zhang, Juan Chen, Mengxi Wang, Dong Wei, Hai Fang, Tong Yin, Jinyan Huang, Saijuan Chen, Hongzhou Lu, Jiang Zhu, Jieming Qu |
| 38 |
[GO] |
2021―Sep―29 |
Author Correction: Mechanical activation of spike fosters SARS-CoV-2 infection |
Wei Hu, Yong Zhang, Panyu Fei, Tongtong Zhang, Danmei Yao, Yufei Gao, Jia Liu, Hui Chen, Qiao Lu, Tenny Mudianto, Xinrui Zhang, Chuxuan Xiao, Yang Ye, Qiming Sun, Jing Zhang, Qi Xie, Pei-Hui Wang, Jun Wang, Zhenhai Li, Jizhong Lou, Wei Chen |
| 39 |
[GO] |
2021―Sep―29 |
Tracing the origins of SARS-CoV-2: lessons learned from the past |
Qihui Wang, Hua Chen, Yi Shi, Alice C. Hughes, William J. Liu, Jingkun Jiang, George F. Gao, Yongbiao Xue, Yigang Tong |
| 40 |
[GO] |
2021―Sep―28 |
Design and development of an oral remdesivir derivative VV116 against SARS-CoV-2 |
Yuanchao Xie, Wanchao Yin, Yumin Zhang, Weijuan Shang, Zhen Wang, Xiaodong Luan, Guanghui Tian, Haji A. Aisa, Yechun Xu, Gengfu Xiao, Jia Li, Hualiang Jiang, Shuyang Zhang, Leike Zhang, H. Eric Xu, Jingshan Shen |
| 41 |
[GO] |
2021―Sep―20 |
Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 |
Shiyu Sun, Yueqi Cai, Tian-Zhang Song, Yang Pu, Lin Cheng, Hairong Xu, Jing Sun, Chaoyang Meng, Yifan Lin, Haibin Huang, Fang Zhao, Silin Zhang, Yu Gao, Jian-Bao Han, Xiao-Li Feng, Dan-Dan Yu, Yalan Zhu, Pu Gao, Haidong Tang, Jincun Zhao, Zheng Zhang, Jiaming Yang, Zhenxiang Hu, Yang-Xin Fu, Yong-Tang Zheng, Hua Peng |
| 42 |
[GO] |
2021―Sep―03 |
Structure-based analyses of neutralization antibodies interacting with naturally occurring SARS-CoV-2 RBD variants |
Hua Xu, Bo Wang, Tian-Ning Zhao, Zi-Teng Liang, Tian-Bo Peng, Xiao-Hui Song, Jia-Jing Wu, You-Chun Wang, Xiao-Dong Su |
| 43 |
[GO] |
2021―Sep―01 |
Timing vaccination against SARS-CoV-2 |
Coline Barnoud, Chen Wang, Christoph Scheiermann |
| 44 |
[GO] |
2021―Aug―31 |
Mechanical activation of spike fosters SARS-CoV-2 viral infection |
Wei Hu, Yong Zhang, Panyu Fei, Tongtong Zhang, Danmei Yao, Yufei Gao, Jia Liu, Hui Chen, Qiao Lu, Tenny Mudianto, Xinrui Zhang, Chuxuan Xiao, Yang Ye, Qiming Sun, Jing Zhang, Qi Xie, Pei-Hui Wang, Jun Wang, Zhenhai Li, Jizhong Lou, Wei Chen |
| 45 |
[GO] |
2021―Aug―25 |
Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants |
Shuo Du, Pulan Liu, Zhiying Zhang, Tianhe Xiao, Ayijiang Yasimayi, Weijin Huang, Youchun Wang, Yunlong Cao, Xiaoliang Sunney Xie, Junyu Xiao |
| 46 |
[GO] |
2021―Aug―02 |
Time of day influences immune response to an inactivated vaccine against SARS-CoV-2 |
Hui Zhang, Yihao Liu, Dayue Liu, Qin Zeng, Liubing Li, Qian Zhou, Mengyuan Li, Jie Mei, Niansheng Yang, Suilin Mo, Qiusheng Liu, Min Liu, Sui Peng, Haipeng Xiao |
| 47 |
[GO] |
2021―Aug―02 |
O-glycosylation pattern of the SARS-CoV-2 spike protein reveals an “O-Follow-N” rule |
Wenmin Tian, Delin Li, Nan Zhang, Guijie Bai, Kai Yuan, Haixia Xiao, Feng Gao, Yang Chen, Catherine C. L. Wong, George Fu Gao |
| 48 |
[GO] |
2021―Jul―15 |
Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2 |
Shiyu Sun, Yueqi Cai, Tian-Zhang Song, Yang Pu, Lin Cheng, Hairong Xu, Jing Sun, Chaoyang Meng, Yifan Lin, Haibin Huang, Fang Zhao, Silin Zhang, Yu Gao, Jian-Bao Han, Xiao-Li Feng, Dan-Dan Yu, Yalan Zhu, Pu Gao, Haidong Tang, Jincun Zhao, Zheng Zhang, Jiaming Yang, Zhenxiang Hu, Yang-Xin Fu, Yong-Tang Zheng, Hua Peng |
| 49 |
[GO] |
2021―Jun―16 |
A cohort autopsy study defines COVID-19 systemic pathogenesis |
Xiao-Hong Yao, Tao Luo, Yu Shi, Zhi-Cheng He, Rui Tang, Pei-Pei Zhang, Jun Cai, Xiang-Dong Zhou, Dong-Po Jiang, Xiao-Chun Fei, Xue-Quan Huang, Lei Zhao, Heng Zhang, Hai-Bo Wu, Yong Ren, Zhen-Hua Liu, Hua-Rong Zhang, Cong Chen, Wen-Juan Fu, Heng Li, Xin-Yi Xia, Rong Chen, Yan Wang, Xin-Dong Liu, Chang-Lin Yin, Ze-Xuan Yan, Juan Wang, Rui Jing, Tai-Sheng Li, Wei-Qin Li, Chao-Fu Wang, Yan-Qing Ding, Qing Mao, Ding-Yu Zhang, Shu-Yang Zhang, Yi-Fang Ping, Xiu-Wu Bian |
| 50 |
[GO] |
2021―Jun―10 |
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target |
Bingqing Xia, Xurui Shen, Yang He, Xiaoyan Pan, Feng-Liang Liu, Yi Wang, Feipu Yang, Sui Fang, Yan Wu, Zilei Duan, Xiaoli Zuo, Zhuqing Xie, Xiangrui Jiang, Ling Xu, Hao Chi, Shuangqu Li, Qian Meng, Hu Zhou, Yubo Zhou, Xi Cheng, Xiaoming Xin, Lin Jin, Hai-Lin Zhang, Dan-Dan Yu, Ming-Hua Li, Xiao-Li Feng, Jiekai Chen, Hualiang Jiang, Gengfu Xiao, Yong-Tang Zheng, Lei-Ke Zhang, Jingshan Shen, Jia Li, Zhaobing Gao |
| 51 |
[GO] |
2021―May―21 |
Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines |
Yunlong Cao, Ayijiang Yisimayi, Yali Bai, Weijin Huang, Xiaofeng Li, Zhiying Zhang, Tianjiao Yuan, Ran An, Jing Wang, Tianhe Xiao, Shuo Du, Wenping Ma, Liyang Song, Yongzheng Li, Xiang Li, Weiliang Song, Jiajing Wu, Shuo Liu, Xuemei Li, Yonghong Zhang, Bin Su, Xianghua Guo, Yangyang Wei, Chuanping Gao, Nana Zhang, Yifei Zhang, Yang Dou, Xiaoyu Xu, Rui Shi, Bai Lu, Ronghua Jin, Yingmin Ma, Chengfeng Qin, Youchun Wang, Yingmei Feng, Junyu Xiao, Xiaoliang Sunney Xie |
| 52 |
[GO] |
2021―May―18 |
SARS-CoV-2 vaccines: anamnestic response in previously infected recipients |
Jyothi N. Purushotham, Neeltje van Doremalen, Vincent J. Munster |
| 53 |
[GO] |
2021―Apr―27 |
Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4 |
Yingchi Zhao, Ming Kuang, Junhong Li, Ling Zhu, Zijing Jia, Xuefei Guo, Yaling Hu, Jun Kong, Hang Yin, Xiangxi Wang, Fuping You |
| 54 |
[GO] |
2021―Apr―23 |
The basis of a more contagious 501Y.V1 variant of SARS-CoV-2 |
Haolin Liu, Qianqian Zhang, Pengcheng Wei, Zhongzhou Chen, Katja Aviszus, John Yang, Walter Downing, Chengyu Jiang, Bo Liang, Lyndon Reynoso, Gregory P. Downey, Stephen K. Frankel, John Kappler, Philippa Marrack, Gongyi Zhang |
| 55 |
[GO] |
2021―Mar―29 |
Structure-based development of three- and four-antibody cocktails against SARS-CoV-2 via multiple mechanisms |
Yao Sun, Lei Wang, Rui Feng, Nan Wang, Yuxi Wang, Dandan Zhu, Xiaorui Xing, Peng Yang, Yanjun Zhang, Weimin Li, Xiangxi Wang |
| 56 |
[GO] |
2021―Mar―23 |
Double insult: flu bug enhances SARS-CoV-2 infectivity |
Shan Su, Zezhong Liu, Shibo Jiang |
| 57 |
[GO] |
2021―Mar―19 |
SARS-CoV-2 spike protein interacts with and activates TLR41 |
Yingchi Zhao, Ming Kuang, Junhong Li, Ling Zhu, Zijing Jia, Xuefei Guo, Yaling Hu, Jun Kong, Hang Yin, Xiangxi Wang, Fuping You |
| 58 |
[GO] |
2021―Mar―18 |
Structural basis for the different states of the spike protein of SARS-CoV-2 in complex with ACE2 |
Renhong Yan, Yuanyuan Zhang, Yaning Li, Fangfei Ye, Yingying Guo, Lu Xia, Xinyue Zhong, Ximin Chi, Qiang Zhou |
| 59 |
[GO] |
2021―Mar―17 |
Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies |
Renhong Yan, Ruoke Wang, Bin Ju, Jinfang Yu, Yuanyuan Zhang, Nan Liu, Jia Wang, Qi Zhang, Peng Chen, Bing Zhou, Yaning Li, Yaping Shen, Shuyuan Zhang, Long Tian, Yingying Guo, Lu Xia, Xinyue Zhong, Lin Cheng, Xiangyang Ge, Juanjuan Zhao, Hong-Wei Wang, Xinquan Wang, Zheng Zhang, Linqi Zhang, Qiang Zhou |
| 60 |
[GO] |
2021―Feb―20 |
Coinfection with influenza A virus enhances SARS-CoV-2 infectivity |
Lei Bai, Yongliang Zhao, Jiazhen Dong, Simeng Liang, Ming Guo, Xinjin Liu, Xin Wang, Zhixiang Huang, Xiaoyi Sun, Zhen Zhang, Lianghui Dong, Qianyun Liu, Yucheng Zheng, Danping Niu, Min Xiang, Kun Song, Jiajie Ye, Wenchao Zheng, Zhidong Tang, Mingliang Tang, Yu Zhou, Chao Shen, Ming Dai, Li Zhou, Yu Chen, Huan Yan, Ke Lan, Ke Xu |
| 61 |
[GO] |
2021―Jan―28 |
The m6A methylome of SARS-CoV-2 in host cells |
Jun’e Liu, Yan-Peng Xu, Kai Li, Qing Ye, Hang-Yu Zhou, Hanxiao Sun, Xiaoyu Li, Liu Yu, Yong-Qiang Deng, Rui-Ting Li, Meng-Li Cheng, Bo He, Jia Zhou, Xiao-Feng Li, Aiping Wu, Chengqi Yi, Cheng-Feng Qin |
| 62 |
[GO] |
2021―Jan―21 |
Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages |
Els Wauters, Pierre Van Mol, Abhishek Dinkarnath Garg, Sander Jansen, Yannick Van Herck, Lore Vanderbeke, Ayse Bassez, Bram Boeckx, Bert Malengier-Devlies, Anna Timmerman, Thomas Van Brussel, Tina Van Buyten, Rogier Schepers, Elisabeth Heylen, Dieter Dauwe, Christophe Dooms, Jan Gunst, Greet Hermans, Philippe Meersseman, Dries Testelmans, Jonas Yserbyt, Sabine Tejpar, Walter De Wever, Patrick Matthys, Johan Neyts, Joost Wauters, Junbin Qian, Diether Lambrechts |
| 63 |
[GO] |
2021―Jan―20 |
Dalbavancin: novel candidate for COVID-19 treatment |
Markus Hoffmann, Yeonhwa Jin, Stefan Pöhlmann |
| 64 |
[GO] |
2021―Jan―08 |
AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells |
Shuai Wang, Zongyang Qiu, Yingnan Hou, Xiya Deng, Wei Xu, Tingting Zheng, Peihan Wu, Shaofang Xie, Weixiang Bian, Chong Zhang, Zewei Sun, Kunpeng Liu, Chao Shan, Aifu Lin, Shibo Jiang, Youhua Xie, Qiang Zhou, Lu Lu, Jing Huang, Xu Li |
| 65 |
[GO] |
2020―Dec―01 |
Structure-based development of human antibody cocktails against SARS-CoV-2 |
Nan Wang, Yao Sun, Rui Feng, Yuxi Wang, Yan Guo, Li Zhang, Yong-Qiang Deng, Lei Wang, Zhen Cui, Lei Cao, Yan-Jun Zhang, Weimin Li, Feng-Cai Zhu, Cheng-Feng Qin, Xiangxi Wang |
| 66 |
[GO] |
2020―Dec―01 |
Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models |
Gan Wang, Meng-Li Yang, Zi-Lei Duan, Feng-Liang Liu, Lin Jin, Cheng-Bo Long, Min Zhang, Xiao-Peng Tang, Ling Xu, Ying-Chang Li, Peter Muiruri Kamau, Lian Yang, Hong-Qi Liu, Jing-Wen Xu, Jie-Kai Chen, Yong-Tang Zheng, Xiao-Zhong Peng, Ren Lai |
| 67 |
[GO] |
2020―Dec―01 |
SARS-CoV-2-induced lung pathology: AHR as a candidate therapeutic target |
Federico Giovannoni, Francisco J. Quintana |
| 68 |
[GO] |
2020―Nov―11 |
Engineered trimeric ACE2 binds viral spike protein and locks it in “Three-up” conformation to potently inhibit SARS-CoV-2 infection |
Liang Guo, Wenwen Bi, Xinling Wang, Wei Xu, Renhong Yan, Yuanyuan Zhang, Kai Zhao, Yaning Li, Mingfeng Zhang, Xia Cai, Shibo Jiang, Youhua Xie, Qiang Zhou, Lu Lu, Bobo Dang |
| 69 |
[GO] |
2020―Nov―06 |
Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19 |
Yuying Liu, Jiadi Lv, Jiangning Liu, Man Li, Jing Xie, Qi Lv, Wei Deng, Nannan Zhou, Yabo Zhou, Jiangping Song, Peng Wang, Chuan Qin, Wei-Min Tong, Bo Huang |
| 70 |
[GO] |
2020―Nov―02 |
The SARS-CoV-2 spike protein: balancing stability and infectivity |
Imre Berger, Christiane Schaffitzel |
| 71 |
[GO] |
2020―Sep―30 |
Effective treatment of SARS-CoV-2-infected rhesus macaques by attenuating inflammation |
Shuaiyao Lu, Jingjing Zhao, Jiebin Dong, Hongqi Liu, Yinhua Zhu, Honggang Li, Liping Liu, Yun Yang, Shicheng Sun, Yifan Song, Yuan Zhao, Ruiping She, Tuoping Luo, Hongkui Deng, Xiaozhong Peng |
| 72 |
[GO] |
2020―Sep―10 |
Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA |
Hui Chen, Yang Cui, Xuling Han, Wei Hu, Min Sun, Yong Zhang, Pei-Hui Wang, Guangtao Song, Wei Chen, Jizhong Lou |
| 73 |
[GO] |
2020―Aug―25 |
A mouse model for SARS-CoV-2 infection by exogenous delivery of hACE2 using alphavirus replicon particles |
Ya-Nan Zhang, Xiao-Dan Li, Zhe-Rui Zhang, Hong-Qing Zhang, Na Li, Jing Liu, Jia-Qi Li, Hua-Jun Zhang, Ze-Jun Wang, Shuo Shen, Zheng-Li Shi, Hong-Ping Wei, Zhi-Ming Yuan, Han-Qing Ye, Bo Zhang |
| 74 |
[GO] |
2020―Aug―18 |
25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor |
Shulong Zu, Yong-Qiang Deng, Chao Zhou, Jie Li, Lili Li, Qi Chen, Xiao-Feng Li, Hui Zhao, Sarah Gold, Jun He, Xiang Li, Changqing Zhang, Heng Yang, Genhong Cheng, Cheng-Feng Qin |
| 75 |
[GO] |
2020―Aug―17 |
A COVID-19 mRNA vaccine encoding SARS-CoV-2 virus-like particles induces a strong antiviral-like immune response in mice |
Jing Lu, Guoliang Lu, Shudan Tan, Jia Xia, Hualong Xiong, Xiaofei Yu, Qingqing Qi, Xiang Yu, Li Li, Hang Yu, Ningshao Xia, Tianying Zhang, Yingjie Xu, Jinzhong Lin |
| 76 |
[GO] |
2020―Aug―05 |
Dysregulated adaptive immune response contributes to severe COVID-19 |
Kuai Yu, Jingjing He, Yongjian Wu, Baosong Xie, Xuefei Liu, Bo Wei, Haibo Zhou, Bingliang Lin, Zhixiang Zuo, Wen Wen, Wenxiong Xu, Bin Zou, Lai Wei, Xi Huang, Penghui Zhou |
| 77 |
[GO] |
2020―Aug―05 |
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 |
Wanbo Tai, Xiujuan Zhang, Aleksandra Drelich, Juan Shi, Jason C. Hsu, Larry Luchsinger, Christopher D. Hillyer, Chien-Te K. Tseng, Shibo Jiang, Lanying Du |
| 78 |
[GO] |
2020―Aug―04 |
SARS-CoV-2 infects human neural progenitor cells and brain organoids |
Bao-Zhong Zhang, Hin Chu, Shuo Han, Huiping Shuai, Jian Deng, Ye-fan Hu, Hua-rui Gong, Andrew Chak-Yiu Lee, Zijiao Zou, Thomas Yau, Wutian Wu, Ivan Fan-Ngai Hung, Jasper Fuk-Woo Chan, Kwok-Yung Yuen, Jian-Dong Huang |
| 79 |
[GO] |
2020―Jul―20 |
Serosurvey of SARS-CoV-2 among hospital visitors in China |
Wenhua Liang, Yongping Lin, Jianping Bi, Jianfu Li, Ying Liang, Sook-San Wong, Mark Zanin, Zifeng Yang, Caichen Li, Ran Zhong, Guowu Jiang, Guang Han, Desheng Hu, Jianxing He, Nanshan Zhong |
| 80 |
[GO] |
2020―Jul―07 |
Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques |
Chao Shan, Yan-Feng Yao, Xing-Lou Yang, Yi-Wu Zhou, Ge Gao, Yun Peng, Lian Yang, Xue Hu, Jin Xiong, Ren-Di Jiang, Hua-Jun Zhang, Xiao-Xiao Gao, Cheng Peng, Juan Min, Ying Chen, Hao-Rui Si, Jia Wu, Peng Zhou, Yan-Yi Wang, Hong-Ping Wei, Wei Pang, Zheng-Fei Hu, Long-Bao Lv, Yong-Tang Zheng, Zheng-Li Shi, Zhi-Ming Yuan |
| 81 |
[GO] |
2020―Jul―06 |
Pulmonary alveolar regeneration in adult COVID-19 patients |
Jingyu Chen, Huijuan Wu, Yuanyuan Yu, Nan Tang |
| 82 |
[GO] |
2020―Jul―01 |
Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients |
Bao-zhong Zhang, Ye-fan Hu, Lin-lei Chen, Thomas Yau, Yi-gang Tong, Jing-chu Hu, Jian-piao Cai, Kwok-Hung Chan, Ying Dou, Jian Deng, Xiao-lei Wang, Ivan Fan-Ngai Hung, Kelvin Kai-Wang To, Kwok Yung Yuen, Jian-Dong Huang |
| 83 |
[GO] |
2020―Jun―30 |
Distinct stem/progenitor cells proliferate to regenerate the trachea, intrapulmonary airways and alveoli in COVID-19 patients |
Yinshan Fang, Helu Liu, Huachao Huang, Haiyan Li, Anjali Saqi, Li Qiang, Jianwen Que |
| 84 |
[GO] |
2020―Jun―15 |
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease |
Chunlong Ma, Michael Dominic Sacco, Brett Hurst, Julia Alma Townsend, Yanmei Hu, Tommy Szeto, Xiujun Zhang, Bart Tarbet, Michael Thomas Marty, Yu Chen, Jun Wang |
| 85 |
[GO] |
2020―Apr―29 |
COVID-19: treating and managing severe cases |
Jingwen Ai, Yang Li, Xian Zhou, Wenhong Zhang |
| 86 |
[GO] |
2020―Apr―28 |
COVID-19: towards understanding of pathogenesis |
Wei Cao, Taisheng Li |
| 87 |
[GO] |
2020―Apr―28 |
Pathological evidence for residual SARS-CoV-2 in pulmonary tissues of a ready-for-discharge patient |
Xiao-Hong Yao, Zhi-Cheng He, Ting-Yuan Li, Hua-Rong Zhang, Yan Wang, Huaming Mou, Qiaonan Guo, Shi-Cang Yu, Yanqing Ding, Xindong Liu, Yi-Fang Ping, Xiu-Wu Bian |
| 88 |
[GO] |
2020―Mar―30 |
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion |
Shuai Xia, Meiqin Liu, Chao Wang, Wei Xu, Qiaoshuai Lan, Siliang Feng, Feifei Qi, Linlin Bao, Lanying Du, Shuwen Liu, Chuan Qin, Fei Sun, Zhengli Shi, Yun Zhu, Shibo Jiang, Lu Lu |
| 89 |
[GO] |
2020―Feb―18 |
Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses |
Tuan M. Nguyen, Yang Zhang, Pier Paolo Pandolfi |
| 90 |
[GO] |
2020―Feb―04 |
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro |
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao |
|
